Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.37 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | LDHA | P00338 | 1/20 | 0.34 |
| ▸ | LDHB | P07195 | 1/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4065015 | 0.78 | TP53 (0.50) | DPP4TP53RECQLOPRL1ADRA1A | |
| SCHEMBL29557462 | 0.77 | HTR2C (0.52) | HTR2AHTR2CHTR2BTAAR1 | |
| SCHEMBL21336326 | 0.77 | CASP1 (0.33) | DPP4SMN1; SMN2 | |
| SCHEMBL30217494 | 0.77 | KDM1A (0.41) | ADRA1AADRA1DADRA1BHTR2CHTR2B | |
| SCHEMBL31053095 | 0.77 | HTR2C (0.52) | HTR2AHTR2CHTR2BTAAR1 | |
| SCHEMBL971145 | 0.77 | KDM1A (0.40) | HTR2AHTR2CHTR2BSMN1; SMN2 | |
| SCHEMBL10336974 | 0.77 | RAB9A (0.41) | RECQLHTR2AHTR2CHTR2BSMN1; SMN2 | |
| SCHEMBL1897406 | 0.77 | TP53 (0.57) | DPP4TP53RECQLOPRL1ADRA1A | |
| Charcoal, Activated SCHEMBL5897477 | 0.74 | TP53 (0.55) | DPP4TP53RECQLOPRL1ADRA1A | |
| SCHEMBL10740295 | 0.73 | LMNA (0.40) | DPP4SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1775276-B1 | Process for the coupling of benzylamines and halogenated aromates | SALTIGO GMBH (DE) | 2012-08-29 | — | — | EP | claimed |
| EP-1775276-B1 | Process for the coupling of benzylamines and halogenated aromates | SALTIGO GMBH (DE) | 2012-08-29 | — | — | EP | disclosed |
| US-7276630-B2 | Process for coupling benzylamines with haloaromatics | SALTIGO GMBH (DE) | 2007-10-02 | — | — | US | disclosed |
| EP-1775276-A1 | Process for the coupling of benzylamines and halogenated aromates | Saltigo GmbH (DE) | 2007-04-18 | — | — | EP | disclosed |
| CN-1939894-A | Process for the coupling of benzylamines and halogenated aromates | SALTIGO GMBH (DE) | 2007-04-04 | — | — | CN | disclosed |
| US-20070073078-A1 | Process for coupling benzylamines with haloaromatics | SALTIGO GMBH (DE) | 2007-03-29 | — | — | US | disclosed |
| CN-1278725-A | Indeno [1,2-c]-naphtho [1,2-C]- and benzo [6,7] cyclohepta [1,2-C] pyrazole derivatives | BASF AG (DE) | 2001-01-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070073078-A1 | Process for coupling benzylamines with haloaromatics | BRD1, BRD2, BRD7 | DPP4 2256/4885TP53 4365/4885RECQL 2970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.